 |
 |
John Stafford wrote: > > Safety concerns which have impeded the use > of a drug effective against Parkinson's > disease may not be justified, according to a > study by a team at the Salpetriere Hospital The report by Y. Agid appears as an editorial in the current Neurology, pp. 858-863, which I shall review in Current Science Reviews for June 1998, if I get around to it. Cheers, Joe J. R. Bruman (818) 789-3694 3527 Cody Road Sherman Oaks, CA 91403-5013